Where’s My Ozempic or Mounjaro? Exploring Supply, Access & Insurance Struggles 2025 [OyuDePbNVBl]

Where’s My Ozempic or Mounjaro? Exploring Supply, Access & Insurance Struggles 2025 [OyuDePbNVBl]

| 1h 28m 28s | Video has closed captioning.

Struggling to find Ozempic or Mounjaro? You're not alone! In this video, we explore the skyrocketing demand and supply shortages of weight loss medications like Ozempic (Semaglutide) and Mounjaro (Tirzepatide). Discover the frustrations of patients and doctors, the impact of insurance barriers, compounded medication bans, and cultural perceptions shaping accessibility in the US and Australia. Whether you're a healthcare professional or someone searching for solutions, this episode breaks it down with evidence-based insights. Stay informed on these hot health topics and join the conversation about the future of obesity treatments. Ozempic = Semaglutide (the US and Australia) Wegovy (= Semaglutide, Australia only, weight loss) Mounjaro = Tirzepatide (the US and Australia Zepbound (= Tirzepatide, the US only, weight loss, sleep apnoea) REFERENCES Weight regain after discontinuing medications like Ozempic and Mounjaro 1. “Discontinuation of semaglutide and weight regain”Diabetes, Obesity and Metabolism (2022) 2. “Here’s How Much Weight People Regain After Stopping Mounjaro or Zepbound” Author: Sarah Fielding; Healthline (2023) 3. “Effect of Continued vs Discontinued Semaglutide Treatment on Weight Maintenance” Authors: Rubino D, Greenway FL, Khalid U, et al.;The Lancet Diabetes & Endocrinology (2021) The Frustration and Struggles of Physicians 1.“Insurance Coverage of Obesity Medications.” JAMA. 2022 2.“Obesity Medications and Access to Care: Challenges in Insurance Coverage.” Obesity Medicine News, 2023. 3. “Barriers to Accessing FDA-Approved Obesity Medications.” American Journal of Managed Care. 2023 4. “Insurance Barriers and Access to Weight Loss Drugs.” Endocrine Reviews, 2023. 5. “Economic Impact of Insurance Denials on Obesity Treatment Access.” Health Affairs. 2023 6. Australian Physicians’ Concerns: RACGP; Simple Online Doctor Australia Accessibility and Supply: TGA.gov.au; RACGP; (Source: Chemist2U) Compounded Medications Ban: RACGP; Diabetes Victoria; Private Health Insurance Landscape; Insurance Business Australia; Bupa FAQs Approval and Prescribing Practices: (Source: TGA, Source: RACGP). PBS Subsidies and Costs: Health.gov.au; MyDr.com.au United States Approval and Prescribing Practices: (Source: FDA, Source: Lilly Pricing Info). Accessibility and Supply: (Source: FDA) Cultural Perception and Media Coverage Australia:(Source: The Australian) United States:(Source: Bloomberg) #Ozempic, #Mounjaro, #WeightLossMedication, #HealthPodcast, #Semaglutide, #Tirzepatide, #ObesityTreatment, #InsuranceBarriers, #Wegovy, #Zepbound, #HealthTips, #WeightLossJourney, #HealthCareAccess, #AustraliaHealth, #USHealth #best over counter diet pills #quantum keto gummy #keto pills at walgreens #acv keto oprah #biolyte keto gummies